FDA drug class

Platelet Aggregation Inhibitors list

Every FDA-approved prescription drug the FDA NDC directory tags with the Platelet Aggregation Inhibitor [EPC] class, with brand names and DEA schedules.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

The FDA NDC directory lists 3 single-ingredient drugs in this class: dipyridamole, eptifibatide, tirofiban. Another 5 combination products include one of them.

Run it in Rivvi

Map your top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Platelet Aggregation Inhibitors (8)

Platelet Aggregation Inhibitors: FDA Platelet Aggregation Inhibitor class
DrugBrand namesTypeNDC listingsDEA schedule
DipyridamoleNone listedSingle ingredient16Not controlled
EptifibatideNone listedSingle ingredient21Not controlled
TirofibanAggrastatSingle ingredient10Not controlled
Aspirin and dipyridamoleNone listedCombination9Not controlled
Butalbital, aspirin and caffeineNone listedCombination5Schedule III
Butalbital, aspirin, caffeine and codeineAscomp with CodeineCombination4Schedule III
Orphenadrine, aspirin and caffeineNorgesic Forte, NorgesicCombination5Not controlled
Oxycodone and aspirinNone listedCombination1Schedule II

FDA established pharmacologic class: Platelet Aggregation Inhibitor [EPC].

Questions

What drugs are Platelet Aggregation Inhibitors?

The FDA NDC directory lists 3 single-ingredient drugs in this class: dipyridamole, eptifibatide, tirofiban. Another 5 combination products include one of them.

Where does this list come from?

From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.

Related

Try it on your own data today.

Free to start. Most teams are using it the same day.